Loading data
INSENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 304.1 m USD | 297.1 m USD | 322.9 m USD | 284.5 m USD | 205.8 m USD |
| Cost of revenue | — | — | 128.6 m USD | 94.9 m USD | 51.8 m USD |
| Research and development expense | 19.4 m USD | 22.7 m USD | 20.3 m USD | 18.3 m USD | 13.8 m USD |
| Selling, general and administrative expense | — | — | 104.3 m USD | 91.1 m USD | 77.3 m USD |
| Operating profit | 30.5 m USD | 30.7 m USD | 38.9 m USD | 46.5 m USD | -4.5 m USD |
| Interest expense | — | — | 27.7 m USD | 25.3 m USD | 44.3 m USD |
| Profit before tax | -5.9 m USD | 1.8 m USD | 11.9 m USD | 23.3 m USD | -42.2 m USD |
| Income tax expense | 11.1 m USD | -63 m USD | 5 m USD | 2.1 m USD | -1.6 m USD |
| Net income (reported basis) | -17 m USD | 64.8 m USD | 6.9 m USD | 21.2 m USD | -40.6 m USD |
| Net income attributable to common shareholders | — | 64.8 m USD | 6.9 m USD | 21.2 m USD | — |
| Basic earnings per share | -0.58 USD/share | 2.27 USD/share | 0.25 USD/share | 0.76 USD/share | -1.66 USD/share |
| Diluted earnings per share | -0.58 USD/share | 2.22 USD/share | 0.24 USD/share | 0.73 USD/share | -1.66 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.